Pharmacological and clinical evaluation of deferasirox formulations for treatment tailoring

Deferasirox (DFX) is the newest among three different chelators available to treat iron overload in iron-loading anaemias, firstly released as Dispersible Tablets (DT) and more recently replaced by Film-Coated Tablets (FCT). In this retrospective observational study, pharmacokinetics, pharmacodynami...

Descripción completa

Detalles Bibliográficos
Autores principales: Piolatto, Andrea, Berchialla, Paola, Allegra, Sarah, De Francia, Silvia, Ferrero, Giovanni Battista, Piga, Antonio, Longo, Filomena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206201/
https://www.ncbi.nlm.nih.gov/pubmed/34131221
http://dx.doi.org/10.1038/s41598-021-91983-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206201/
https://www.ncbi.nlm.nih.gov/pubmed/34131221
http://dx.doi.org/10.1038/s41598-021-91983-w

Ejemplares similares